Gland Pharma Limited has received approval from the United States Food and Drug Administration (USFDA) for Latanoprost ...

Hyderabad: Gland Pharma Limited, a generic injectable-focused pharmaceutical company, has received approval from the United ...

Gland Pharma receives USFDA approval for Latanoprost Ophthalmic Solution, strengthening its position in the US pharmaceutical ...

Our Bureau, Bengaluru Tuesday, December 3, 2024, 12:40 Hrs [IST] Gland Pharma, a generic injectable–focused pharmaceut ...

Latanoprost Ophthalmic Solution is used for treatment of high eye pressure, or intraocular pressure (IOP) in patients with ...

The uptick in Gland Pharma share came after the company said that it has received approval from the United States Food and ...

According to IQVIA, the product had US sales of approximately USD 111.6 million for the twelve months ending 2023.

Purpose: We investigated the intraocular pressure (IOP) variations after switching from 0.005% latanoprost to 0.01% bimatoprost in open-angle glaucoma patients who experienced IOP elevation during ...